MaaT Pharma S.A.

MAAT.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€20,154€24,280€35,248€43,304
Short-Term Investments€66€34€63€0
Receivables€1,514€5,164€1,047€3,507
Inventory€64€190€47€33
Other Curr. Assets€5,845€2,326€5,719€425
Total Curr. Assets€27,643€31,994€42,124€47,269
Property Plant & Equip (Net)€8,603€9,172€966€1,107
Goodwill€0€0€0€0
Intangibles€1,769€1,343€1,200€806
Long-Term Investments€0€422€436€238
Tax Assets€0€0-€436-€238
Other NC Assets€486€0€436€237
Total NC Assets€10,858€10,937€2,602€2,150
Other Assets€0€0€0€1
Total Assets€38,501€42,931€44,726€49,420
Liabilities
Payables€8,827€6,349€4,507€34
Short-Term Debt€3,127€3,455€2,969€1,254
Tax Payable€92€57€47€34
Deferred Revenue€0€0€0€727
Other Curr. Liab.€2,515€1,661€1,741€2,654
Total Curr. Liab.€14,561€11,522€9,217€4,703
LT Debt€12,831€10,620€8,356€4,552
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€773€323€322€308
Total NC Liab.€13,604€10,943€8,698€4,861
Other Liabilities€0€0€0€0
Cap. Leases€6,000€5,195€626€786
Total Liabilities€28,165€22,465€17,915€9,564
Equity
Pref Stock€0€0€0€0
Common Stock€1,398€1,162€994€988
Retained Earnings-€26,304-€17,857-€12,370-€7,596
AOCI€0€0€0€0
Other Equity€35,242€37,161€38,187€46,464
Total Equity€10,336€20,466€26,811€39,856
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€38,501€42,931€44,726€49,420
Net Debt-€4,196-€10,205-€23,923-€37,498